HomeInsightsStock Comparison

Jagsonpal Pharmaceuticals Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Jagsonpal Pharmaceuticals Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Last Updated on: Jun 24, 2025

Key Highlights

  • The Latest Trading Price of Jagsonpal Pharmaceuticals Ltd is ₹ 216.75 as of 24 Jun 15:40.
  • The P/E Ratio of Jagsonpal Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Torrent Pharmaceuticals Ltd changed from 32.6 on March 2020 to 53.2 on March 2024 . This represents a CAGR of 10.29% over 5 years.
  • The Market Cap of Jagsonpal Pharmaceuticals Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Torrent Pharmaceuticals Ltd changed from ₹ 33361 crore on March 2020 to ₹ 88030 crore on March 2024 . This represents a CAGR of 21.42% over 5 years.
  • The revenue of Jagsonpal Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Torrent Pharmaceuticals Ltd for the Mar '25 is ₹ 2941 crore as compare to the Dec '24 revenue of ₹ 2842 crore. This represent the growth of 3.48%.
  • The ebitda of Jagsonpal Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Torrent Pharmaceuticals Ltd for the Mar '25 is ₹ 922 crore as compare to the Dec '24 ebitda of ₹ 947 crore. This represent the decline of -2.64%.
  • The net profit of Jagsonpal Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Torrent Pharmaceuticals Ltd changed from ₹ 378 crore to ₹ 498 crore over 8 quarters. This represents a CAGR of 14.78% .
  • The Dividend Payout of Jagsonpal Pharmaceuticals Ltd changed from 16.65 % on March 2020 to 58.86 % on March 2024 . This represents a CAGR of 28.73% over 5 yearsThe Dividend Payout of Torrent Pharmaceuticals Ltd changed from 57.71 % on March 2020 to 69.83 % on March 2024 . This represents a CAGR of 3.89% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Jagsonpal Pharmaceuticals Ltd

  • Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana.
  • The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs.
  • Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd. The company has a strategic alliance with Fidia Spa, Italy; and B Spofola, Czechoslovakia; to manufacture sophisticated drugs in India.
  • It has tied up with another Israel-based company, Makhteshim Chemical Works, for acquiring the marketing rights of an anti-oxidant product.
  • In 1994, the company has also promoted Aresco Financial Services, a new financial company.

About Torrent Pharmaceuticals Ltd

  • Torrent Pharmaceuticals Limited is a leading player in the Indian pharmaceutical sector, concentrating on the chronic and sub-chronic therapeutic segments.
  • The Company has established itself as a leader in developing niche pharmaceutical solutions through its patient-centric innovation.
  • The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
  • It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Germany, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 12 countries with major setups in the US, Germany and Brazil.

Jagsonpal Pharmaceuticals Ltd News Hub

News

Jagsonpal Pharmaceuticals allots 53,000 equity shares under ESOP

Jagsonpal Pharmaceuticals has allotted 53,000 equity shares under ESOP on 11 June 2025. Wi...

Read more

11 Jun 2025 18:15

News

Board of Jagsonpal Pharmaceuticals recommends final dividend

Jagsonpal Pharmaceuticals announced that the Board of Directors of the Company at its meet...

Read more

07 May 2025 09:28

News

Jagsonpal Pharmaceuticals to announce Quarterly Result

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on ...

Read more

30 Apr 2025 10:51

News

Jagsonpal Pharmaceuticals allots 39,850 equity shares under ESOP

Jagsonpal Pharmaceuticals has allotted 39,850 equity shares under ESOP. With this allotmen...

Read more

21 Apr 2025 14:14

News

Jagsonpal Pharmaceuticals allots 11,575 equity shares under ESOP

Jagsonpal Pharmaceuticals has allotted 11,575 equity shares under ESOP. Consequent to the ...

Read more

13 Mar 2025 18:58

News

Jagsonpal Pharmaceuticals allots 22,150 equity shares under ESOP

Jagsonpal Pharmaceuticals has allotted 22,150 equity shares of Rs. 2/- each under JPL ESOP...

Read more

17 Feb 2025 12:41

Torrent Pharmaceuticals Ltd News Hub

News

Torrent Pharmaceuticals Ltd spurts 0.03%, gains for five straight sessions

Torrent Pharmaceuticals Ltd rose for a fifth straight session today. The stock is quoting ...

Read more

09 Jun 2025 13:00

News

Board of Torrent Pharmaceuticals recommends final dividend

Torrent Pharmaceuticals announced that the Board of Directors of the Company at its meetin...

Read more

20 May 2025 20:32

News

Torrent Pharmaceuticals to conduct board meeting

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 20...

Read more

14 May 2025 14:06

News

Torrent Pharmaceuticals announces resignation of ED (Strategic Planning)

Torrent Pharmaceuticals announced that Pranav Mehta, Executive Director (Strategic Plannin...

Read more

27 Feb 2025 18:47

News

Torrent Pharmaceuticals Ltd rises for third consecutive session

Torrent Pharmaceuticals Ltd gained for a third straight session today. The stock is quotin...

Read more

07 Feb 2025 13:05

News

Torrent Pharmaceuticals Ltd slips for fifth straight session

Torrent Pharmaceuticals Ltd is down for a fifth straight session today. The stock is quoti...

Read more

04 Feb 2025 13:35

SWOT Analysis Of Torrent Pharmaceuticals Ltd

Strength

4

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Jagsonpal Pharmaceuticals Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Torrent Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Jagsonpal Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Jagsonpal Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd

Which company has a larger market capitalization, Jagsonpal Pharmaceuticals Ltd or Torrent Pharmaceuticals Ltd?

Market cap of Jagsonpal Pharmaceuticals Ltd is 1,443 Cr while Market cap of Torrent Pharmaceuticals Ltd is 107,116 Cr

What are the key factors driving the stock performance of Jagsonpal Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd?

The stock performance of Jagsonpal Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jagsonpal Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd?

As of June 24, 2025, the Jagsonpal Pharmaceuticals Ltd stock price is INR ₹217.2. On the other hand, Torrent Pharmaceuticals Ltd stock price is INR ₹3165.1.

How do dividend payouts of Jagsonpal Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd compare?

To compare the dividend payouts of Jagsonpal Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions